He writes: “In view of the market re-rating and our positive outlook, we now peg the stock to 17 times FY2025 price-to-earnings ratio (P/E), in line with peers’ forward P/E and 1.5 standard deviation (s.d.) above its historical mean forward P/E.”
Analysts are pleased following Frencken Group’s (Frencken) improved earnings of 9.9% y-o-y up $19.9 million for the 1HFY2025 ended June.
RHB Bank Singapore’s (RHB) Alfie Yeo, with his “buy” call and raised target price of $1.68 from $1.48 previously, remains “upbeat” on Frencken on the back of the growth across its semiconductor and medical segments.
